Treatment of BK virus-associated hemorrhagic cystitis with low-dose intravenous cidofovir in patients undergoing allogeneic hematopoietic cell transplantation

Korean Journal of Internal Medicine

Volumn 30, Issue 2, 2015, Pages 212-218

  Lee, Seung Shin ^a   Ahn, Jae Sook ^a   Jung, Sung Hoon ^a   Ahn, Seo Yeon ^a   Kim, Jae Yong ^a   Jang, Hee Chang ^a   Kang, Seung Ji ^a   Jang, Mi Ok ^a   Yang, Deok Hwan ^a   Kim, Yeo Kyeoung ^a   Lee, Je Jung ^a   Kim, Hyeoung Joon ^a  

^a Chonnam National University Research Institute of Medical Sciences   (South Korea)

Author keywords

BK virus; Cidofovir; Hemorrhagic cystitis

Indexed keywords

CALCINEURIN INHIBITOR; CIDOFOVIR; CREATININE; CYCLOSPORIN A; GLUCOCORTICOID; HYALURONIC ACID; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; ANTIVIRUS AGENT; CYTOSINE; PHOSPHONIC ACID DERIVATIVE;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BK VIRUS; BK VIRUS INFECTION; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GRAFT VERSUS HOST REACTION; HEMORRHAGIC CYSTITIS; HUMAN; LOW DRUG DOSE; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; NONHUMAN; RETROSPECTIVE STUDY; SIDE EFFECT; THROMBOCYTOPENIA; URINALYSIS; VIREMIA; VIRUS LOAD; YOUNG ADULT; ADVERSE EFFECTS; ALLOTRANSPLANTATION; ANALOGS AND DERIVATIVES; CYSTITIS; DRUG ADMINISTRATION; DRUG EFFECTS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; POLYOMAVIRUS INFECTIONS; TIME FACTOR; TREATMENT OUTCOME; TUMOR VIRUS INFECTIONS; VIROLOGY;

ADMINISTRATION, INTRAVENOUS; ADULT; ANTIVIRAL AGENTS; BK VIRUS; CYSTITIS; CYTOSINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; MALE; ORGANOPHOSPHONATES; POLYOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; TUMOR VIRUS INFECTIONS; VIRAL LOAD;

EID: 84924420751     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2015.30.2.212     Document Type: Article

References (27)

1. Bedi A, Miller CB, Hanson JL, et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995;13:1103-1109.
2. Gorczynska E, Turkiewicz D, Rybka K, et al. Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2005;11:797-804.
3. Sencer SF, Haake RJ, Weisdorf DJ. Hemorrhagic cystitis after bone marrow transplantation: risk factors and complications. Transplantation 1993;56:875-879.
4. Silva Lde P, Patah PA, Saliba RM, et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type. Haematologica 2010;95:1183-1190.
5. Cesaro S, Hirsch HH, Faraci M, et al. Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study. Clin Infect Dis 2009;49:233-240.
6. Azzi A, Cesaro S, Laszlo D, et al. Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients. J Clin Virol 1999;14:79-86.
7. Cesaro S, Brugiolo A, Faraci M, et al. Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: a survey from the Italian association of pediatric hematology oncology-bone marrow transplantation group. Bone Marrow Transplant 2003;32:925-931.
8. Miodosky M, Abdul-Hai A, Tsirigotis P, et al. Treatment of post-hematopoietic stem cell transplantation hemorrhagic cystitis with intravesicular sodium hyaluronate. Bone Marrow Transplant 2006;38:507-511.
9. Savona MR, Newton D, Frame D, Levine JE, Mineishi S, Kaul DR. Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant. Bone Marrow Transplant 2007;39:783-787.
10. Mackey MC. Intravesicular cidofovir for the treatment of polyomavirus-associated hemorrhagic cystitis. Ann Pharmacother 2012;46:442-446.
11. Gonzalez-Fraile MI, Canizo C, Caballero D, et al. Cidofovir treatment of human polyomavirus-associated acute haemorrhagic cystitis. Transpl Infect Dis 2001;3:44-46.
12. Gaziev J, Paba P, Miano R, et al. Late-onset hemorrhagic cystitis in children after hematopoietic stem cell transplantation for thalassemia and sickle cell anemia: a prospective evaluation of polyoma (BK) virus infection and treatment with cidofovir. Biol Blood Marrow Transplant 2010;16:662-671.
13. Brugieres L, Hartmann O, Travagli JP, et al. Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: incidence, clinical course, and outcome. J Clin Oncol 1989;7:194-199.
14. De Clercq E. In search of a selective antiviral chemotherapy. Clin Microbiol Rev 1997;10:674-693.
15. Andrei G, Snoeck R, Vandeputte M, De Clercq E. Activities of various compounds against murine and primate polyomaviruses. Antimicrob Agents Chemother 1997;41:587-593.
16. Leung AY, Chan MT, Yuen KY, et al. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2005;40:528-537.
17. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. diagnosis and staging working group report. Biol Blood Marrow Transplant 2005;11:945-956.
18. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on acute GVHD grading. Bone Marrow Transplant 1995;15:825-828.
19. Hirsch HH. BK virus: opportunity makes a pathogen. Clin Infect Dis 2005;41:354-360.
20. Siguier M, Sellier P, Bergmann JF. BK-virus infections: a literature review. Med Mal Infect 2012;42:181-187.
21. Ahsan N. Polyomaviruses and Human Diseases. New York: Springer Science+Business Media, 2006.
22. Gilis L, Morisset S, Billaud G, et al. High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2014;49:664-670.
23. Kloos RQ, Boelens JJ, de Jong TP, Versluys B, Bierings M. Hemorrhagic cystitis in a cohort of pediatric transplantations: incidence, treatment, outcome, and risk factors. Biol Blood Marrow Transplant 2013;19:1263-1266.
24. Perazella MA. Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity. Am J Med Sci 2003;325:349-362.
25. Appelbaum FR, Thomas ED; Wiley InterScience (Online service), et al. Thomas’ Hematopoietic Cell Transplantation: Stem Cell Transplantation. 4th ed. Oxford: Wiley-Blackwell, 2009.
26. Ganguly N, Clough LA, Dubois LK, et al. Low-dose cidofovir in the treatment of symptomatic BK virus infection in patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis of an algorithmic approach. Transpl Infect Dis 2010;12:406-411.
27. Kwon HJ, Kang JH, Lee JW, Chung NG, Kim HK, Cho B. Treatment of BK virus-associated hemorrhagic cystitis in pediatric hematopoietic stem cell transplant recipients with cidofovir: a single-center experience. Transpl Infect Dis 2013;15:569-574.